Overview

Carbamazepine Extended-Release for the Treatment of Bipolar Depression

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.
Phase:
Phase 4
Details
Lead Sponsor:
Tuscaloosa Research & Education Advancement Corporation
Collaborator:
Shire
Treatments:
Carbamazepine